Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in NVS — Novartis AG

CIK 1907281 PLYMOUTH, MA

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$1,439,159
+$50,051 QoQ
Shares Held
9,183
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#515
of 1,603 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $6,968,762 across 10 Drug Manufacturers - General names. NVS ranks #2 (20.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVS
Novartis AG
This page
9,183 $1,439,159

All Filings in NVS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,439,159 9,183
2026-03-31 $1,389,108 9,094
2025-12-31 $1,245,517 9,034
2025-09-30 $1,162,367 9,064
2025-06-30 $1,084,007 8,958
2025-03-31 $984,591 8,832
2024-12-31 $857,301 8,810
2024-09-30 $1,010,220 8,783
2024-06-30 $937,912 8,810
2024-03-31 $17,024 176
2023-12-31 $901,662 8,930
2023-06-30 $891,640 8,836
2023-03-31 $802,700 8,725
2022-12-31 $780,554 8,604
2022-09-30 $637,039 8,381
2022-06-30 $692,807 8,196
2022-03-31 $696,033 7,932
2021-12-31 $693,812 7,932